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Mycoplasma pneumoniae is one of the most
common causes of respiratory infections in
children and adults worldwide [1,2]. This
bacterial pathogen is estimated to be re-
sponsible for at least one case of pneu-
monia per 1,000 persons and .100,000
adult hospitalizations per year in the
United States alone [1–3]. The infection
is mostly mild, but all age groups can
experience more severe disease, and fatal
cases occasionally occur.
Extrapulmonary manifestations are a
notable aspect of M. pneumoniae infections
and are seen in up to 25% of infected
persons [1,2,4]. It has been pointed out that
the high prevalence of M. pneumoniae infec-
tion in most populations predisposes to
reporting concurrent but perhaps unrelated
events as if they were part of the disease [2],
and this may be so particularly for single
case reports confirmed only by serologic
response [1,2]. Among reported extrapul-
monary manifestations, joint, skin, hemato-
logic, cardiovascular, nervous, and immune
system disorders are solidly documented by
culture, polymerase chain reaction (PCR),
immunohistochemical analysis, and/or se-
rologic analysis [1,2,4–7].
Characteristics of M. pneumoniae suggest
the possibility that this mycoplasma could
adhere to erythrocytes during extrapulmo-
nary dissemination and such adherence
could contribute to pathogenesis. First, M.
pneumoniae has been cultured from extrapul-
monary infection sites such as synovial fluid
and pericardial fluid [1,2,4], so reaching
such sites demonstrates that M. pneumoniae
must be able to enter the blood stream.
Second, it has long been known that M.
pneumoniae adheres to human erythrocytes in
vitro [8,9], and electron microscopy shows
M. pneumoniae does not merely adhere to
erythrocytes but deformsthem by producing
depressions in the erythrocyte surface in
which the mycoplasmas adhere closely [10].
Third, M. pneumoniae belongs to the same
phylogenetic group that contains the hemo-
tropic mycoplasmas; these uncultivated
mycoplasmas parasitize erythrocytes of
mammalian hosts and produce acute and
chronic blood infections with hemolytic
anemia and other illness [11]. Hemotropic
mycoplasmas deform host erythrocytes and
produce depressions in which they also
adhere closely, and it is striking that the
erythrocyte adherence of M. pneumoniae seen
in vitro [10] appears to be identical to that
observed in hemotropic mycoplasma eryth-
rocyte infections [12]. Further, M. pneumoniae
famously causes half or more of patients to
produce erythrocyte cold agglutinins, and
this character also is shared with hemotropic
mycoplasmas [11]. We note that there is a
report that a hemotropic mycoplasma can
invade erythrocytes [13].
Some notion of the frequency of blood
entry by M. pneumoniae may be provided by
PCR studies that have demonstrated M.
pneumoniae DNA in serum [14–16]. M.
pneumoniae DNA has been detected in sera
from pediatric patients both with pneu-
monia (1/25) and, significantly, without
pneumonia (10/17), and in some cases M.
pneumoniae DNA was detected for periods
of more than 20 days, suggesting a
bacteremia [14]. A real-time PCR study
that utilized archival sera mainly from
adults found M. pneumoniae DNA in 15 of
29 seropositive patient sera [16]. If these
findings and other PCR reports detecting
M. pneumoniae DNA in interior tissues often
reflects the presence of organisms, as is
thought by many investigators, then blood
entry by M. pneumoniae might not be rare.
It may be necessary, nonetheless, to
examine blood from a number of patients
because of variables that could affect the
presence of M. pneumoniae in a given
sample. These include the frequency with
which infection leads to blood entry, the
infection stage(s) during which M. pneumo-
niae may enter the blood, the dwell period
in blood, and the patient’s immune status.
The genotype of the infecting strain [17–
20] also could be a factor in blood entry.
Rapid identification of M. pneumoniae
infections by PCR [21–23] permits selec-
tion of appropriate cases for investigating
the possibility that M. pneumoniae adheres to
patient erythrocytes. The following infor-
mation about hemotropic mycoplasma
infections may be helpful in examining this
possibility. Hemotropic mycoplasma infec-
tions have been detected mainly by visual
search for erythrocyte-attached mycoplas-
mas in Wright-Giemsa blood smears, a
relatively insensitive method, by animal
inoculation, and by PCR (the current
standard), but also of course by other
molecular biological and instrument-based
methods, including fluorescent-activated
cell sorting. The percentage of infected
erythrocytes in stained smears can vary
from extremely high values (one or more
mycoplasmas are seen attached to nearly
everyerythrocyteinmost microscopefields)
to very low values (searches of replicate
smears from a PCR positive blood are
negative), depending on, importantly, not
only the stage of the infection but also the
Mycoplasma species. Immuofluorescent or
DNA staining substantially improves visual
searching, and fluorescent staining allows
more sensitive examination of archival
Wright-Giemsa stained slides [24]. Specific
staining also permits identification of my-
coplasmas free in the plasma that by light
microscopy might be mistaken for nonbac-
terial particles.
Obtaining proof that M. pneumoniae has
the ability to adhere to patient erythrocytes
would enlarge our understanding of M.
pneumoniae pathogenicity and provide an
intriguing new perspective on how this
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